Clinical Trial Update: Prophylactic Effect of Probiotic Streptococcus Salivarius eK12 Against Recurrent Streptococcus Pyogenes Pharyngotonsillitis Infection in Pediatrics [NA]

View source ↗

Summary

A pediatric clinical trial is examining whether the probiotic Streptococcus Salivarius eK12 can prevent recurrent Streptococcus pyogenes pharyngotonsillitis inf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Streptococcal Pharyngitis

Drugs mentioned

• Streptococcus Salivarius eK12 probiotic (Streptococcus Salivarius eK12)

Snippet

Sponsor: Liaquat University of Medical & Health Sciences | Conditions: Streptococcus Pyogenes Pharyngotonsillitis | NA | Status: RECRUITING